CD24 expression predicts distant metastasis in extrahepatic bile duct cancer

World Journal of Gastroenterology

Volumn 19, Issue 9, 2013, Pages 1438-1443

  Kim, Kyubo ^a   Min, Hye Sook ^a   Chie, Eui Kyu ^a   Jang, Jin Young ^a   Kim, Sun Whe ^a   Han, Sae Won ^a   Oh, Do Youn ^a   Im, Seock Ah ^a   Kim, Tae You ^a   Bang, Yung Jue ^a   Jang, Ja June ^a   Ha, Sung W ^a  

^a Seoul National University   (South Korea)

Author keywords

Adjuvant chemoradiotherapy; CD24; Distant metastasis; Extrahepatic bile duct cancer; Tissue microarray

Indexed keywords

CAPECITABINE; CD24 ANTIGEN; FLUOROPYRIMIDINE; FLUOROURACIL;

ADULT; AGED; ARTICLE; BILE DUCT CANCER; CANCER PROGNOSIS; CANCER STAGING; CORRELATION ANALYSIS; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; EXTRAHEPATIC BILE DUCT CANCER; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; RADIATION DOSE; TISSUE MICROARRAY;

EID: 84875122978     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i9.1438     Document Type: Article

References (26)

1. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005; 366: 1303-1314. [PMID: 16214602]
2. Jarnagin WR, Ruo L, Little SA, Klimstra D, D'Angelica M, DeMatteo RP, Wagman R, Blumgart LH, Fong Y. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer 2003; 98: 1689-1700. [PMID: 14534886]
3. Kim JK, Ha HK, Han DJ, Auh YH. CT analysis of postoperative tumor recurrence patterns in periampullary cancer. Abdom Imaging 2003; 28: 384-391. [PMID: 12719910]
4. de Castro SM, Kuhlmann KF, van Heek NT, Busch OR, Offerhaus GJ, van Gulik TM, Obertop H, Gouma DJ. Recurrent disease after microscopically radical (R0) resection of periampullary adenocarcinoma in patients without adjuvant therapy. J Gastrointest Surg 2004; 8: 775-784; discussion 784. [PMID: 15531230]
5. Borghero Y, Crane CH, Szklaruk J, Oyarzo M, Curley S, Pisters PW, Evans D, Abdalla EK, Thomas MB, Das P, Wistuba II, Krishnan S, Vauthey JN. Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. Ann Surg Oncol 2008; 15: 3147-3156. [PMID: 18754070 DOI: 10.1245/s10434-008-9998-7]
6. Gwak HK, Kim WC, Kim HJ, Park JH. Extrahepatic bile duct cancers: surgery alone versus surgery plus postoperative radiation therapy. Int J Radiat Oncol Biol Phys 2010; 78: 194-198. [PMID: 19910130 DOI: 10.1016/j.ijrobp.2009.07.003]
7. Kim TH, Han SS, Park SJ, Lee WJ, Woo SM, Moon SH, Yoo T, Kim SS, Kim SH, Hong EK, Kim DY, Park JW. Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer. Int J Radiat Oncol Biol Phys 2011; 81: e853-e859. [PMID: 21497455 DOI: 10.1016/j.ijrobp.2010.12.019]
8. Bonet Beltrán M, Allal AS, Gich I, Solé JM, Carrió I. Is adjuvant radiotherapy needed after curative resection of extrahepatic biliary tract cancers? A systematic review with a meta- analysis of observational studies. Cancer Treat Rev 2012; 38: 111-119. [PMID: 21652148 DOI: 10.1016/j.ctrv.2011.05.003]
9. Shinohara ET, Mitra N, Guo M, Metz JM. Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas. Int J Radiat Oncol Biol Phys 2009; 74: 1191-1198. [PMID: 19201549 DOI: 10.1016/j.ijrobp.2008.09.017]
10. Kim K, Chie EK, Jang JY, Kim SW, Han SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience. Am J Clin Oncol 2012; 35: 136-140. [PMID: 21325937 DOI: 10.1097/ COC.0b013e318209aa29]
11. Zamboglou C, Messmer MB, Becker G, Momm F. Stereotactic radiotherapy in the liver hilum. Basis for future studies. Strahlenther Onkol 2012; 188: 35-41. [PMID: 22194027 DOI: 10.1007/s00066-011-0002-2]
12. Kristiansen G, Sammar M, Altevogt P. Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol 2004; 35: 255-262. [PMID: 15339045]
13. Kristiansen G, Denkert C, Schlüns K, Dahl E, Pilarsky C, Hauptmann S. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am J Pathol 2002; 161: 1215-1221. [PMID: 12368195]
14. Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schlüns K, Denkert C, Dahl E, Pilarsky C, Altevogt P, Guski H, Dietel M. CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res 2003; 9: 4906-4913. [PMID: 14581365]
15. Kristiansen G, Schlüns K, Yongwei Y, Denkert C, Dietel M, Petersen I. CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients. Br J Cancer 2003; 88: 231-236. [PMID: 12610508]
16. Darwish NS, Kim MA, Chang MS, Lee HS, Lee BL, Kim YI, Kim WH. Prognostic significance of CD24 expression in gastric carcinoma. Cancer Res Treat 2004; 36: 298-302. [PMID: 20368819 DOI: 10.4143/crt.2004.36.5.298]
17. Weichert W, Denkert C, Burkhardt M, Gansukh T, Bellach J, Altevogt P, Dietel M, Kristiansen G. Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin Cancer Res 2005; 11: 6574-6581. [PMID: 16166435]
18. Kwon GY, Ha H, Ahn G, Park SY, Huh SJ, Park W. Role of CD24 protein in predicting metastatic potential of uterine cervical squamous cell carcinoma in patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2007; 69: 1150-1156. [PMID: 17692475]
19. Yang XR, Xu Y, Yu B, Zhou J, Li JC, Qiu SJ, Shi YH, Wang XY, Dai Z, Shi GM, Wu B, Wu LM, Yang GH, Zhang BH, Qin WX, Fan J. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery. Clin Cancer Res 2009; 15: 5518-5527. [PMID: 19706825 DOI: 10.1158/1078-0432. CCR-09-0151]
20. Sano A, Kato H, Sakurai S, Sakai M, Tanaka N, Inose T, Saito K, Sohda M, Nakajima M, Nakajima T, Kuwano H. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma. Ann Surg Oncol 2009; 16: 506-514. [PMID: 19050962 DOI: 10.1245/s10434-008-0252-0]
21. Agrawal S, Kuvshinoff BW, Khoury T, Yu J, Javle MM, Le-Vea C, Groth J, Coignet LJ, Gibbs JF. CD24 expression is an independent prognostic marker in cholangiocarcinoma. J Gastrointest Surg 2007; 11: 445-451. [PMID: 17436128]
22. AJCC. AJCC Cancer staging handbook. 6th ed. New York: Springer-Verlag, 2002
23. Riener MO, Vogetseder A, Pestalozzi BC, Clavien PA, Probst-Hensch N, Kristiansen G, Jochum W. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract. Hum Pathol 2010; 41: 1558-1565. [PMID: 20621328 DOI: 10.1016/j.humpath.2009.12.016]
24. Su MC, Hsu C, Kao HL, Jeng YM. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma. Cancer Lett 2006; 235: 34-39. [PMID: 16125303]
25. Kobayashi A, Miwa S, Nakata T, Miyagawa S. Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma. Br J Surg 2010; 97: 56-64. [PMID: 19937985 DOI: 10.1002/ bjs.6788]
26. Keeratichamroen S, Leelawat K, Thongtawee T, Narong S, Aegem U, Tujinda S, Praditphol N, Tohtong R. Expression of CD24 in cholangiocarcinoma cells is associated with disease progression and reduced patient survival. Int J Oncol 2011; 39: 873-881. [PMID: 21687942 DOI: 10.3892/ ijo.2011.1088]